跳至主要内容
临床试验/ITMCTR2000003471
ITMCTR2000003471招募中1 期

To explore the regulation mechanism of the target gene miR21 and miR21--ECP--IL-4 network of allergic rhinitis with qi deficiency and blood stasis syndrome by Ke-Min-Qi-Dan nasal spray: a single-center, prospective, randomized controlled clinical trial

The Hospital of Chengdu University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • (1) In accordance with the diagnostic criteria of western medicine for allergic rhinitis;
  • (2) In accordance with the diagnostic criteria of traditional Chinese medicine of qi deficiency and blood stasis syndrome;
  • (3) Those who have not received any treatment in the past week;
  • (4) Age between 18 and 65, regardless of gender;
  • (5) Those who agree to participate in this project and sign informed consent.

排除标准

  • (1) Patients with severe diseases of brain, heart, kidney, digestive system and hematopoietic system.And the mentally ill;
  • (2) Patients with severe chronic rhinitis, significantly deviated nasal septum, or severe nasal polyps, sinusitis, or asthma;
  • (3) Patients who have received or are receiving immunospecific therapy;
  • (4) Intended pregnant women, pregnant women or lactating women;
  • Patients with any of the above are excluded.

研究者

发起方
The Hospital of Chengdu University of Chinese Medicine

相似试验